Regarding the new coronavirus vaccine developed by American pharmaceutical giant Pfizer and others, the EU-European Union drug regulator has announced that it will be able to store at normal refrigerator temperature for a new period of 5 days to 1 month. I gave a guideline.
Pharmaceutical companies say the results are based on new data.
On the 17th, EU drug regulator EMA = European Medicines Agency issued a new guideline to "recommend changes in storage conditions" for the new coronavirus vaccine developed by Pfizer and German pharmaceutical company BioNTech.
According to this, the period during which the thawed unopened vaccine can be stored at 2 to 8 degrees, which is the same level as a normal refrigerator, has been greatly extended from the previous 5 days to 1 month = 31 days.
EMA said it was the result of analyzing newly submitted data from pharmaceutical companies, and BioNTech said in a statement, "The change in storage conditions is based on new data that confirms that quality will be maintained for one month." I made it clear.
The EU has set a goal of vaccination of 70% of adults in the region by summer, but since the percentage of people who have been vaccinated at least once has reached 36%, further vaccination is being encouraged. "The increased flexibility in storage and handling will have a significant impact on vaccination planning and transportation in EU member states," the EMA said.